Journey Medical Corporation DERM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$9.59M+16.1% | -$11.43M— | —— | —— | —— | ||
| $5.95M-5.3% | $6.29M+6.7% | $5.89M+3.8% | $5.68M-5.6% | $6.02M-1.4% | ||
| -$6.7M+46.1% | -$12.44M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $12.85M-20.8% | $16.23M-24.2% | $21.42M+48.9% | $14.38M-25.3% | $19.25M+11.3% | ||
| —— | —— | $2.49M+169% | -$3.62M-21.2% | -$2.99M+58.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Journey Medical Corporation generate?
- Journey Medical Corporation (DERM) generated -$6.7M in operating cash flow over the trailing twelve months.
- Where does Journey Medical Corporation's cash flow data come from?
- Every line is extracted from Journey Medical Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
